Correlation Between 4D Molecular and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and X4 Pharmaceuticals, you can compare the effects of market volatilities on 4D Molecular and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and X4 Pharmaceuticals.
Diversification Opportunities for 4D Molecular and X4 Pharmaceuticals
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between FDMT and XFOR is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of 4D Molecular i.e., 4D Molecular and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between 4D Molecular and X4 Pharmaceuticals
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, 4D Molecular Therapeutics is 1.54 times less risky than X4 Pharmaceuticals. The stock trades about -0.13 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 100.00 in X4 Pharmaceuticals on September 1, 2024 and sell it today you would lose (61.00) from holding X4 Pharmaceuticals or give up 61.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. X4 Pharmaceuticals
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| X4 Pharmaceuticals |
4D Molecular and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and X4 Pharmaceuticals
The main advantage of trading using opposite 4D Molecular and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| 4D Molecular vs. Tff Pharmaceuticals | 4D Molecular vs. Eliem Therapeutics | 4D Molecular vs. Inhibrx | 4D Molecular vs. Enliven Therapeutics |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |